Efficacy and safety of dasotraline in attention-deficit hyperactivity disorder: A systematic review and meta-analysis

CONCLUSIONS: Dasotraline 4 mg (in children) and 6 mg (in adults) can improve the clinical outcome in patients with ADHD by improving symptoms and global functioning with acceptable tolerability.PROSPERO Registration number: CRD42022321979.

via https://pubmed.ncbi.nlm.nih.gov/38778858/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20240605011004&v=2.18.0.post9+e462414